Novacyt Announces Proposed Acquisition of Primer Design Ltd

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has entered into a definitive agreement to acquire the entire share capital of Primer Design Ltd, a profitable and rapidly growing UK molecular diagnostics company.

Download press release